Study Evaluating AGG-523 in Subjects With Osteoarthritis

A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Parallel-Group Study of the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of AGG-523 Administered Orally to Subjects With Mild to Moderate Osteoarthritis

This study will evaluate the effect of AGG-523 administration on biomarkers related to osteoarthritis. Safety and tolerability of AGG-523 will also be assessed.

Inclusion:

• Mild to moderate Osteoarthritis of the target knee.
• Subjects must be generally healthy but enrolled with stable chronic illness if well controlled.